Malignant melanotic schwannian tumor: A clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma"

American Journal of Surgical Pathology

Volumn 38, Issue 1, 2014, Pages 94-105

  Torres Mora, Jorge ^a   Dry, Sarah ^b   Li, Xinmin ^b   Binder, Scott ^b   Amin, Mitual ^c   Folpe, Andrew L ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Carney complex; gene expression profiling; immunohistochemistry; melanotic schwannoma; PRKAR1A; psammomatous melanotic schwannoma; sarcoma

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; CHILD; CLASSIFICATION; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; NEURILEMOMA; NOMENCLATURE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SKIN TUMOR; TUMOR RECURRENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEURILEMMOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84891627098     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182a0a150     Document Type: Article

References (35)

1. MillarWG. A malignant melanotic tumor of ganglion cells arising from thoracic sympathetic ganglion. J Pathol Bacteriol. 1932;35:351-357.
2. Rowlands D, Edwards C, Collins F. Malignant melanotic schwannoma of the bronchus. J Clin Pathol. 1987;40:1449-1455.
3. Thornton CM, Handley J, Bingham EA, et al. Psammomatous melanotic schwannoma arising in the dermis in a patient with Carney's complex. Histopathology. 1992;20:71-73.
4. Shields JA, Font RL, Eagle RC Jr, et al. Melanotic schwannoma of the choroid. Immunohistochemistry and electron microscopic observations. Ophthalmology. 1994;101:843-849.
5. Ranjan A, Chacko G, Chandi SM. Intracerebellar melanotic schwannoma: a case report. Br J Neurosurg. 1995;9:687-689.
6. Akiyoshi T, Ueda Y, Yanai K, et al. Melanotic schwannoma of the pancreas: report of a case. Surg Today. 2004;34:550-553.
7. Carney JA. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol. 1990;14:206-222.
8. Vallat-Decouvelaere AV, Wassef M, Lot G, et al. Spinal melanotic schwannoma: a tumour with poor prognosis. Histopathology. 1999; 35:558-566.
9. Zhang HY, Yang GH, Chen HJ, et al. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma. Chin Med J. 2005;118:1451-1461.
10. Kindblom LG, Meis-Kindblom JM, Nelson JS, et al. Melanotic schwannoma. A study of 42 cases (abstract). Lab Invest. 1995;72:7.
11. Masson P. Melanogenesis system. Nevi and melanomas. Pathol Annu. 1967;2:351-397.
12. Baroffio A, Dupin E, Le Douarin NM. Clone-forming ability and differentiation potential of migratory neural crest cells. Proc Natl Acad Sci USA. 1988;85:5325-5329.
13. Dickersin GR. The electron microscopic spectrum of nerve sheath tumors. Ultrastruct Pathol. 1987;11:103-146.
14. Rhodes AR, Silverman RA, Harrist TJ, et al. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the "LAMB" syndrome. J Am Acad Dermatol. 1984;10:72-82.
15. Radin R, Kempf RA. Carney complex: report of three cases. Radiology. 1995;196:383-386.
16. Sheth S, Li X, Binder S, et al. Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis. Mod Pathol. 2011;24:343-354.
17. Ried K, Rao E, Schiebel K, et al. Gene duplications as a recurrent theme in the evolution of the human pseudoautosomal region 1: isolation of the gene ASMTL. Hum Mol Genet. 1998;7:1771-1778.
18. Pratap J, Galindo M, Zaidi SK, et al. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res. 2003;63:5357-5362.
19. Fu YS, Kaye GI, Lattes R. Primary malignant melanocytic tumors of the sympathetic ganglia, with an ultrastructural study of one. Cancer. 1975;36:2029-2041.
20. Carrasco CA, Rojas-Salazar D, Chiorino R, et al. Melanotic nonpsammomatous trigeminal schwannoma as the first manifestation of Carney complex: case report. Neurosurgery. 2006;59: E1334-E1335; discussion E1335.
21. Horvath A, Bertherat J, Groussin L, et al. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. Hum Mutat. 2010;31:369-379.
22. Kirschner LS, Sandrini F, Monbo J, et al. Genetic hetero geneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet. 2000;9: 3037-3046.
23. Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex). Ann N Y Acad Sci. 2002;968:3-21.
24. Veugelers M, Wilkes D, Burton K, et al. Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci USA. 2004;101: 14222-14227.
25. Kim MJ, Choi J, Khang SK, et al. Primary intraosseous melanotic schwannoma of the fibula associated with the Carney complex. Pathol Int. 2006;56:538-542.
26. Gaujoux S, Tissier F, Ragazzon B, et al. Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association. J Clin Endocrinol Metab. 2011;96:E1888-E1895.
27. Zembowicz A, Knoepp SM, Bei T, et al. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol. 2007;31:1764-1775.
28. Miettinen M, Fernandez M, Franssila K, et al. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol. 2001;25:205-211.
29. Gray MH, Rosenberg AE, Dickersin GR, et al. Glial fibrillary acidic protein and keratin expression by benign and malignant nerve sheath tumors. Hum Pathol. 1989;20:1089-1096.
30. Kleihues P, Cavenee WK, International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press; 2000.
31. Scheithauer BW, Woodruff JM, Erlandson RA, et al. Tumors of the Peripheral Nervous System. Washington, DC: Armed Forces Institute of Pathology; 1999.
32. Guillou L, Benhattar J, Gengler C, et al. Translocation-positive lowgrade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol. 2007;31:1387-1402.
33. Hornick JL, Bosenberg MW, Mentzel T, et al. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257-1267.
34. Lieberman PH, Brennan MF, Kimmel M, et al. Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer. 1989;63:1-13.
35. Meis-Kindblom JM, Bergh P, Gunterberg B, et al. Extraskeletal myxoid chondrosarcoma: a reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol. 1999;23:636-650.